Trial Profile
Study of baseline tau burden measured by [18F]GTP1, a tau PET tracer developed to assess tau pathology in AD
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2018
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 03 Oct 2018 New trial record